Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

35.60
Delayed Data
As of Feb 24
 -0.18 / -0.50%
Today’s Change
30.89
Today|||52-Week Range
57.81
-0.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
AssetsCash736.9M2.0B2.2B2.7B
 
 
 
 
 
Short Term Investment Cash-1.7B1.2B196.7M652.0M
 
 
 
 
 
Cash & Short Term Investments1.6B2.4B2.6B3.0B
 
 
 
 
 
 
ReceivablesReceivables3.1B3.1B2.6B3.1B
 
 
 
 
 
 
InventoriesInventories2.0B2.0B2.2B2.0B
 
 
 
 
 
 
Current AssetsOther Current Assets401.8M409.2M412.6M342.0M
 
 
 
 
 
Current Assets7.1B7.9B7.8B8.5B
 
 
 
 
 
 
Total AssetsIntangible Assets329.9M314.9M430.0M385.0M
 
 
 
 
 
Other Assets329.9M314.9M430.0M385.0M
 
 
 
 
 
Total Assets12.6B13.2B13.2B13.8B
 
 
 
 
 
 
LiabilitiesAccounts Payable572.0M796.4M673.4M852.7M
 
 
 
 
 
Short Term Debt62.1M60.6M68.8M32.5M
 
 
 
 
 
Other Current Liabilities4.9B4.7B4.7B5.3B
 
 
 
 
 
Other Liabilities6.3B6.2B6.3B6.7B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-917.1M-664.4M-404.6M-378.7M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
 
Total Liabilities6.9B6.8B6.9B7.4B
 
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock0.000.000.00----
Common Equity5.7B6.4B6.2B6.4B
 
 
 
 
 
Total Shareholder Equity5.7B6.4B6.2B6.4B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.1B2.0B2.0B--
 
 
 
 
 
Addtl. Info.No data currently available for this section.